Binding of glucocorticoids on human skin in vitro;BINDUNG VON GLUCOCORTICOIDEN AN MENSCHLICHER HAUT IN VITRO

H+G Zeitschrift fur Hautkrankheiten

Volumn 71, Issue 1, 1996, Pages 23-27

  Bonsman, U ^a   Rohdewald, P ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

glucocorticoids; human skin; tissue binding

Indexed keywords

BETAMETHASONE VALERATE; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; PREDNICARBATE; PREDNISOLONE; PREDNISOLONE 17 ETHYL CARBONATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PHARMACOKINETICS; SKIN;

EID: 0030022423     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hein, R. (1993): Effect of Glucocorticosteroids on Number and Function of Connective-Tissue Cells. in: Topical Glucocorticoids with increased Benefit Risk Ratio. Current Problems in Dermatology Vol. 21. Hrsg. H.C. Korting & H.I. Maibach, pp. 73-78, Basel, Karger-Verlag.
2. Khalafallah, N. & W.J. Jusko (1984): Determination and prediction of tissue binding of prednisolone in the rabbit. J.Pharm.Sci. 73, 362-366.
3. Kimura, M , Y. Tarumoto, S. Nakane, S. Otomo (1986): Comparative toxicity study of Hydrocortisone-17-butyrate-21-propionate (HBP) Ointment and other topical Corticosteroids in rats. Drugs Exptl. Clin Res, XII (8), 643-652.
4. Rohdewald, P., U. Bonsmann & P. Hogger (1995): Die Bindung inhalativer Glukokortikoide an menschliches Lungengewebe in vitro. In: Neue Aspekte der inhalativen Glukokortikoid-Therapie des Asthma bronchiale. Hrsg. W. Leupold & D. Nolte, pp. 14 - 27, München, DustnVerlag.
5. Scavone, J.M , H. Friedman, D.J. Greenblatt & R.I. Shader (1987): Effect of age, body composition and lipid solubility on benzodiazepine tissue distribution in rats. Arzneim.Forsch. 37, 2-6.
6. Schalla, W., B. Busch-Heidger, F. Hevert (1994): Ansätze zur Optimierung topischer Kortikoide: Erste Belege anhand des Zeitverlaufs der Vasokonstriktion nach epi- und intrakutaner Applikation. H + G Band 69, 3, 166-170